Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Burkitt Lymphoma 27Leukemia, Biphenotypic, Acute 15Leukemia, Myeloid, Acute 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Myelodysplastic Syndromes 9Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma 6Leukemia, Myeloid, Accelerated Phase 6Blast Crisis 6Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Graft vs Host Disease 5Osteosarcoma 4Medulloblastoma 4Down Syndrome 4Urinary Bladder Neoplasms 3Recurrence 3Primary Myelofibrosis 3Neoplasm Metastasis 3Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Juvenile 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Thrombocythemia, Essential 2Rhabdoid Tumor 2Polycythemia Vera 2

Interventions

pembrolizumab 12Pemetrexed 9Cisplatin 9Nivolumab 8Carboplatin 8Ipilimumab 7Cyclophosphamide 6fludarabine 5durvalumab 4tremelimumab 2Radiotherapy, Intensity-Modulated 2Gemcitabine 2Cerebral Decortication 2tocilizumab 1tislelizumab 1tazemetostat 1sotorasib 1ruxolitinib 1osimertinib 1olaparib 1obinutuzumab 1naptumomab estafenatox 1fludarabine phosphate 1decitabine and cedazuridine drug combination 1bintrafusp alfa protein, human 1avelumab 1atezolizumab 1Tumor Burden 1Tablets 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma × Methotrexate × 1 year × Clear all
NCT02611037 2025-12-18

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
34 enrolled 12 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡